Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 13/20 | 0.73 |
| ▸ | MMP2 | P08253 | 13/20 | 0.73 |
| ▸ | MMP9 | P14780 | 13/20 | 0.73 |
| ▸ | EGFR | P00533 | 9/20 | 0.73 |
| ▸ | MAOB | P27338 | 2/20 | 0.73 |
| ▸ | MAOA | P21397 | 1/20 | 0.73 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19501046 | 1.00 | MMP1 (0.73) | MMP1MMP2MMP9EGFRMAOB | |
| SCHEMBL19501838 | 0.89 | MMP1 (0.86) | MMP1MMP2MMP9EGFRMAOB | |
| SCHEMBL10492424 | 0.88 | MMP1 (0.80) | MMP1MMP2MMP9EGFRMAOB | |
| SCHEMBL10492426 | 0.88 | MMP1 (0.80) | MMP1MMP2MMP9EGFRMAOB | |
| SCHEMBL1959389 | 0.86 | MMP1 (0.70) | MMP1MMP2MMP9EGFRMAOB | |
| SCHEMBL530137 | 0.86 | MMP1 (0.70) | MMP1MMP2MMP9EGFRMAOB | |
| N-Phenylcinnamamide SCHEMBL3667414 | 0.85 | MMP1 (1.00) | MMP1MMP2MMP9EGFRMAOB | |
| N-Phenylcinnamamide SCHEMBL4205896 | 0.85 | MMP1 (1.00) | MMP1MMP2MMP9EGFRMAOB | |
| N-Phenylcinnamamide SCHEMBL2682029 | 0.85 | MMP1 (1.00) | MMP1MMP2MMP9EGFRMAOB | |
| SCHEMBL19501005 | 0.84 | MMP1 (0.78) | MMP1MMP2MMP9EGFRMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3505357-B1 | RECORDING MATERIAL AND RECORDING SHEET | NIPPON SODA CO (JP) | 2022-06-29 | — | — | EP | disclosed |
| US-11142015-B2 | Recording material, and recording sheet | NIPPON SODA CO., LTD. (JP) | 2021-10-12 | — | — | US | disclosed |
| US-20200180335-A1 | RECORDING MATERIAL AND RECORDING SHEET | NIPPON SODA CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
| EP-3505357-A1 | RECORDING MATERIAL AND RECORDING SHEET | Nippon Soda Co., Ltd. (JP) | 2019-07-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200180335-A1 | RECORDING MATERIAL AND RECORDING SHEET | SCN1A, SCN1B, SCN2A | MMP1 1234/4885MMP2 1596/4885MMP9 547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.